Jane Street Group, LLC Greenwich Life Sciences, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$8.31 - $20.32 $55,153 - $134,863	6,637 Added 47.39%	20,642 $411,000
Q4 2023 Feb 14, 2024	BUY	$7.77 - $12.3 $108,818 - $172,261	14,005 New	14,005 $147,000
Q1 2023 May 15, 2023	BUY	$12.12 - $20.8 $224,341 - $385,008	18,510 New	18,510 $255,000
Q1 2022 May 17, 2022	SELL	$16.3 - $24.65 $139,691 - $211,250	-8,570 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$21.76 - $39.43 $36,535 - $66,202	1,679 Added 24.37%	8,570 $209,000
Q3 2021 Nov 16, 2021	BUY	$38.65 - $46.11 $53,646 - $64,000	1,388 Added 25.22%	6,891 $269,000
Q2 2021 Aug 16, 2021	BUY	$31.24 - $53.6 $171,913 - $294,960	5,503 New	5,503 $247,000

1.1M

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $158M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.